Advertisement

Topics

Prescient Therapeutics Ltd Company Profile

01:31 EDT 17th June 2019 | BioPortfolio


News Articles [861 Associated News Articles listed on BioPortfolio]

Funding round pulls in $10M for Prescient Surgical

A round of Series B financing led by Baxter Ventures has brought in $10 million for Prescient Surgical.  -More- 

Prescient Surgical brings in $6mm in Series A round

Prescient Surgical Inc. (devices to prevent surgical site infection) raised $6mm in its Series A financing. According to the Form D, 33 investors participated.

Prescient Surgical closes $10mm Series B

Prescient Surgical Inc. (devices to fend off surgical site infection) raised $10mm in its Series B financing led by Baxter Ventures, which was joined by returning shareholders Summation Health, CWC He...

Ernst Haeckel’s prescient view

Prescient Therapeutics Ltd PTX Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryPrescient Therapeutics Ltd Prescient Therapeutics, formerly Virax Holdings Ltd, is a clinical stage oncology company that develops novel drugs for the treatment of solid and hematological cance...

How Three People With HIV Became Virus-Free Without HIV Drugs

You’re not entirely human. Our DNA contains roughly 100,000 pieces of viral DNA, totaling 8 percent of our entire genome. Most are ancient relics from long-forgotten invasions; but to HIV patients, ...

How Three People With HIV Became Virus-Free Without Drugs

You’re not entirely human. Our DNA contains roughly 100,000 pieces of viral DNA, totaling 8 percent of our entire genome. Most are ancient relics from long-forgotten invasions; but to HIV patients, ...

Prescient Surgical Raises $10 Million in Series B Investment

Baxter Ventures leads round to accelerate availability of CleanCision, first-in-class, advanced therapy for surgical patients that fights and defends against the sources of surgic...

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]

NA

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]

NA

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [476 Associated PubMed Articles listed on BioPortfolio]

The use of fast photochemical oxidation of proteins coupled with mass spectrometry in protein therapeutics discovery and development.

Structural analysis of protein therapeutics is a challenging task owing to complexities associated with large molecular size and 3D structures. Recent advances in fast photochemical oxidation of prote...

Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.

There is mounting evidence supporting the use of biologic therapeutics for the management of noninfectious uveitis (NIU). This review highlights: biologics with documented efficacy in NIU; agents with...

CRISPR: a promising tool for lipid physiology and therapeutics.

The purpose is to review recent progress in applying the CRISPR/Cas9 system to lipid metabolism and therapeutics.

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro.

In recent times, co-delivery of therapeutics has emerged as a promising strategy for treating dreadful diseases such as cancer.

Advancing Nucleic Acid Therapeutics by Setting Uniform Standards for Experimental Controls.

Clinical Trials [179 Associated Clinical Trials listed on BioPortfolio]

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas

The purpose of this first-in-human study of CX-072 is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-072 administered i...

A Study of BBI503 in Combination With Selected Anti-Cancer Therapeutics in Adult Patients With Advanced Cancer

This is an open label, multi-center, Phase 1/2 study of BBI503 administered in combination with selected anti-cancer therapeutics in adult patients with advanced cancer. The goal of the st...

Companies [1341 Associated Companies listed on BioPortfolio]

Prescient Medical, Inc.

Prescient Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. The company is the recipient of the...

Prescient Medical Inc.

Prescient Medical, Inc. is a privately held medical device company dedicated to reducing deaths from heart attacks, the leading cause of death in much of the world. The company is the recipient of the...

Prescient Therapeutics Ltd

Prescient Surgical, Inc.

Based in San Carlos, Calif., Prescient Surgical, Inc. is a medical device innovator that makes advanced tools and technologies to fight and defend against the sources of s...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

More Information about "Prescient Therapeutics Ltd" on BioPortfolio

We have published hundreds of Prescient Therapeutics Ltd news stories on BioPortfolio along with dozens of Prescient Therapeutics Ltd Clinical Trials and PubMed Articles about Prescient Therapeutics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prescient Therapeutics Ltd Companies in our database. You can also find out about relevant Prescient Therapeutics Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record